ElevenLabs—ElevenLabs partnered with ALS and aphasia advocacy groups to provide free voice cloning for patients losing the ability to speak
ElevenLabs partnered with the ALS Association, Aphasia Recovery Connection and other neurological disability advocacy groups beginning in late 2023 to provide free professional-grade voice cloning to patients facing progressive loss of speech, allowing them to communicate via AAC devices and synthesised speech in their own voice. The program reached more than 2,500 patients by mid-2025. Critics noted ElevenLabs benefited reputationally from the program while continuing to enable widespread voice-fraud harms, but the program's clinical impact has been independently documented.
Scoring Impact
| Topic | Direction | Relevance | Contribution |
|---|---|---|---|
| Accessibility | +toward | primary | +1.00 |
| Healthcare Access | +toward | secondary | +0.50 |
| Human-Centered AI | +toward | secondary | +0.50 |
| Overall incident score = | +0.381 | ||
Score = avg(topic contributions) × significance (medium ×1) × confidence (0.57)
Evidence (1 signal)
ElevenLabs partnered with ALS Association for free voice preservation for patients
ElevenLabs' partnership announcements with the ALS Association and Aphasia Recovery Connection from late 2023 detailed free professional voice-cloning access for patients facing progressive loss of speech, reaching 2,500+ patients by mid-2025.